Financials
Income statement
Fiscal date | Feb 2025 | Nov 2024 | Aug 2024 | May 2024 |
---|---|---|---|---|
Total reported revenue | 143.9M | 143M | 145M | 144M |
Cost of revenue | 38M | 31M | 51M | 48M |
Gross profit | 105.9M | 112M | 94M | 96M |
Operating expense | ||||
Research & development | 23.8M | 27M | 37M | 42M |
Selling general and admin | 76.2M | 61M | 67M | 78M |
Other operating expenses | — | — | — | — |
Operating income | 2.1M | 20M | -21M | -36M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | 2M |
Other income expense | -2.7M | -1M | 3M | 4M |
Pretax income | -6.5M | 19M | -18M | -34M |
Tax provision | 1M | 7M | 1M | 8M |
Net income | -7M | -11M | -19M | -42M |
Basic EPS | — | 0.0 | 0.0 | -0.1 |
Diluted EPS | — | 0.0 | 0.0 | -0.1 |
Basic average shares | — | 591.2M | 590.5M | 589.8M |
Diluted average shares | — | 593.5M | 590.5M | 589.8M |
EBITDA | 11.9M | 34M | -11M | -23M |
Net income from continuing op. | -7M | -11M | -19M | -42M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |